# Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease

> **NCT04836429** · PHASE1 · TERMINATED · sponsor: **Roswell Park Cancer Institute** · enrollment: 5 (actual)

## Conditions studied

- Lung Non-Small Cell Carcinoma
- Pleural Disorder

## Interventions

- **DRUG:** Porfimer Sodium
- **PROCEDURE:** Video-Assisted Thoracic Surgery
- **DRUG:** Photodynamic Therapy
- **DEVICE:** Intraoperative PDT

## Key facts

- **NCT ID:** NCT04836429
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-10
- **Primary completion:** 2024-02-03
- **Final completion:** 2025-01-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04836429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04836429, "Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04836429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*